Endo-microbials for improved production animal performance

The problem

Increasing consumer and regulatory pressure to end the use of antibiotics and growth promoter products in the animal protein industry.

The solution

Endo-microbials for improving livestock health and performance while concurrently replacing antibiotics.

Our engagement

Anterra participated in the Series B financing. Our co-investors include Temasek, Builders VC, Cavallo Ventures, and ADM.